115 related articles for article (PubMed ID: 35786827)
1. Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy.
Chen X; Jia F; Huang Y; Jin Q; Ji J
ACS Appl Bio Mater; 2022 Jul; 5(7):3544-3553. PubMed ID: 35786827
[TBL] [Abstract][Full Text] [Related]
2. CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma.
Zhang Y; Yu R; Zhao C; Liang J; Zhang Y; Su H; Zhao J; Wu H; Xu S; Zhang Z; Wang L; Zou X; Zhu Y; Zhang S; Lv Y
Adv Sci (Weinh); 2024 Jan; 11(1):e2305279. PubMed ID: 37968249
[TBL] [Abstract][Full Text] [Related]
3. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy.
Zhao X; Yang X; Wang X; Zhao X; Zhang Y; Liu S; Anderson GJ; Kim SJ; Li Y; Nie G
ACS Nano; 2021 Sep; 15(9):14149-14161. PubMed ID: 34478262
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
5. An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer.
Ji T; Li S; Zhang Y; Lang J; Ding Y; Zhao X; Zhao R; Li Y; Shi J; Hao J; Zhao Y; Nie G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):3438-45. PubMed ID: 26759926
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment.
Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J
Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201
[TBL] [Abstract][Full Text] [Related]
7. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
[TBL] [Abstract][Full Text] [Related]
8. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.
Feng J; Xu M; Wang J; Zhou S; Liu Y; Liu S; Huang Y; Chen Y; Chen L; Song Q; Gong J; Lu H; Gao X; Chen J
Biomaterials; 2020 May; 241():119907. PubMed ID: 32120315
[TBL] [Abstract][Full Text] [Related]
9. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
10. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
12. Breaking the stromal barrier in pancreatic cancer: Advances and challenges.
Chakkera M; Foote JB; Farran B; Nagaraju GP
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189065. PubMed ID: 38160899
[TBL] [Abstract][Full Text] [Related]
13. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
14. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
15. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem.
Zhou X; Zhang P; Liu N; Zhang X; Lv H; Xu W; Huo M
J Control Release; 2023 Sep; 361():161-177. PubMed ID: 37536546
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
17. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
Yu Y; Schuck K; Friess H; Kong B
Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
[TBL] [Abstract][Full Text] [Related]
18. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
19. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
Li Y; Zhao Z; Liu H; Fetse JP; Jain A; Lin CY; Cheng K
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45390-45403. PubMed ID: 31769963
[TBL] [Abstract][Full Text] [Related]
20. Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4
Gorchs L; Fernández Moro C; Bankhead P; Kern KP; Sadeak I; Meng Q; Rangelova E; Kaipe H
Front Immunol; 2019; 10():847. PubMed ID: 31068935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]